Methods for evaluating effects of an irinotecan + 5-fluorouracil/leucovorin (IFL) regimen in an orthotopic metastatic colorectal cancer model utilizing in vivo bioluminescence imaging

Methods in Molecular Biology

Volumn 602, Issue , 2010, Pages 235-252

  Surguladze, David ^a   Steiner, Philipp ^a   Prewett, Marie ^a   Tonra, James R ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

5 FU; bioluminescence imaging; HT 29; irinotecan; leucovorin; lymph node metastasis; metastatic colorectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CAMPTOTHECIN; DRUG DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; VITAMIN B COMPLEX;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMOLUMINESCENCE; COLORECTAL TUMOR; CULTURE TECHNIQUE; FEMALE; HUMAN; METHODOLOGY; MOUSE; NUDE MOUSE; PATHOLOGY; RANDOMIZATION; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CHEMILUMINESCENT MEASUREMENTS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MICE; MICE, INBRED BALB C; MICE, NUDE; RANDOM ALLOCATION; TREATMENT OUTCOME; VITAMIN B COMPLEX;

EID: 77449116481     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-058-8_14     Document Type: Article

References (15)

1. Fogh J., Orfeo T., Tiso J., Sharkey F.E., Fogh J.M., Daniels W.P. (1980) Twentythree new human tumor lines established in nude mice. Exp Cell Biol 48, 229-239. (Pubitemid 10134150)
2. Morikawa K., Walker S.M., Nakajima M., Pathak S., Jessup J.M., Fidler I.J. (1988) Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48, 6863-6871. (Pubitemid 19012219)
3. Hoffman R.M. (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17, 343-359. (Pubitemid 30135902)
4. Fidler I.J. (1995) Critical factors in the biology of human cancer metastasis. Am Surg 61, 1065-1066.
5. Hoffman R.M. (1994) Orthotopic is orthodox: why are orthotopic-transplant metastatic models different from all other models? J Cell Biochem 56, 1-3. (Pubitemid 24288102)
6. Kubota T. (1994) Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. J Cell Biochem 56, 4-8. (Pubitemid 24288103)
7. Lo D.S., Pollett A., Siu L.L., Gallinger S., Burkes R.L. (2008) Prognostic significance of mesenteric nodules in patients with stage III colorectal cancer. Cancer 112, 50-4.
8. Wu Z.Y., Wan J., Li J.H., Zhao G., Yao Y, Du J.L., et al. (2007) Prognostic value of lateral lymph node metastasis for advanced low rectal cancer. World J Gastroenterol 13, 6048-6052. (Pubitemid 350238274)
9. Berger A.C., Sigurdson E.R., LeVoyer T., Hanlon A., Mayer R.J., Macdonald J.S., Catalano P.J.,Haller D.G. (2005) Colon cancer survival associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23, 8706-8712. (Pubitemid 46211514)
10. Schumacher P., Dineen S., Barnett C., Fleming J., Anthony T. (2007) The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg 194, 827-832. (Pubitemid 350086537)
11. Kashtan H., Rabau M., Mullen J.B.M., Wong A.H.C., Roder J.C., Shpitz B. (1992) Intra-rectal injection of tumor cells: a novel animal model of rectal cancer. Surg Oncol 1, 251-256.
12. Tsutsumi S., Kuwano H., Morinaga N., Shimura T., Aso T. (2001) Animal model of para-aortic lymph node metastasis. Cancer Lett 169, 77-85. (Pubitemid 32532099)
13. Jenkins D.E., Hornig Y.S., Oei Y., Dusich J., Purchio T. (2005) Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastasis in immune deficient mice. Breast Cancer Res 7, R444-R454.
14. Jenkins D.E., Yu S.-F., Hornig Y.S., Purchio T., Contag P.R. (2003) In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3 M-luc-C6 cells in murine models of human prostate cancer. Clin Exp Metastasis 20, 745-756. (Pubitemid 38019276)
15. Saltz L.B., Cox J.V., Blanke C., Rosen L.S., Fehrenbacher L., Moore M.J., Maroun J.A., Ackland S.P., Locker P.K., Pirotta N., Elfring G.L., Miller L.L. (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343, 905-914.